1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0555-0572
  5. NDC Package Code: 0555-0572-35 Methotrexate

NDC Package 0555-0572-35 Methotrexate

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0555-0572-35
Package Description:
36 TABLET in 1 BOTTLE
Product Code:
0555-0572
Proprietary Name:
Methotrexate
Non-Proprietary Name:
Methotrexate
Substance Name:
Methotrexate Sodium
Usage Information:
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.
11-Digit NDC Billing Format:
00555057235
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
36 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 105585 - methotrexate 2.5 MG Oral Tablet
  • RxCUI: 105585 - methotrexate 2.5 MG (as methotrexate sodium) Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • METHOTREXATE SODIUM 2.5 mg/1
    • Pharmacologic Class(es):
  • Folate Analog Metabolic Inhibitor - [EPC] (Established Pharmacologic Class)
  • Folic Acid Metabolism Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA081099
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-01-1990
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0555-0572-35 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00555057235J8610Methotrexate oral 2.5 mg2.5 MG3613636

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0555-0572-02100 TABLET in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0555-0572-35?

    The NDC Packaged Code 0555-0572-35 is assigned to a package of 36 tablet in 1 bottle of Methotrexate, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 0555-0572 included in the NDC Directory?

    Yes, Methotrexate with product code 0555-0572 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on November 01, 1990 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0555-0572-35?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 36.

    What is the 11-digit format for NDC 0555-0572-35?

    The 11-digit format is 00555057235. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20555-0572-355-4-200555-0572-35